Quantcast

Latest Ulcerative colitis Stories

2014-10-13 12:27:24

U.S. and international grantees will receive funds to support innovative, collaborative approaches to investigate potential new treatments and therapies for Inflammatory Bowel Disease. OAKLAND, Calif., Oct. 13, 2014 /PRNewswire-USNewswire/ -- The Kenneth Rainin Foundation announced today that it will grant $2.2 million to scientists to conduct Inflammatory Bowel Disease (IBD) research. The Rainin Foundation offers support for cutting-edge projects that typically are not eligible for funding...

2014-10-08 08:26:55

DUBLIN, Oct. 8, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Crohn's Disease Drug Market and Pipeline Analysis" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Under the umbrella of inflammatory bowel diseases, Crohn's disease and ulcerative colitis are two most common disorders. Though both these disorders have similar symptoms, the difference arises in the areas affected in the gastrointestinal tract (GI tract). The Crohn's...

2014-10-07 12:31:27

PREPOPIK a prescription bowel prep for colonoscopy offers the lowest volume of active prep solution -- only 10 ounces PARSIPPANY, N.J., Oct. 7, 2014 /PRNewswire/ -- Colonoscopy is an important and widely used screening tool for colorectal cancer, but for many patients the bowel-preparation process is more uncomfortable than the procedure itself. To offer an alternative choice in bowel preparation, Ferring Pharmaceuticals Inc. will introduce a new cranberry flavor option of PREPOPIK...

2014-09-18 04:21:05

Company Recently Initiated Phase II in Bullous Pemphigoid CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel, Sept. 18, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (NASDAQ: IMNP; "Immune" or "the Company") announces today that it has initiated the screening of patients for a Phase II proof of concept clinical trial exploring the safety and efficacy of bertilimumab in the treatment of ulcerative colitis (UC). Dr. Daniel Teper, Chairman and CEO of Immune comments: "Bertilimumab is...

2014-08-21 08:28:09

Sigma-Tau Pharmaceuticals Goal is to Broaden Consumer Awareness of VSL#3 and Meet Consumers at the Shelf; Pharmacy Cards Rolling Out At Stores Nationwide GAITHERSBURG, Md., Aug. 21, 2014 /PRNewswire/ -- Consumers have gotten used to seeing shelf cards in place of full product packages in certain categories of products, such as cold and flu, when either price or ingredients are deemed an issue for the store. Now, in an effort to offer consumers a different type of probiotic, one that...

2014-08-20 16:23:24

NEW YORK, Aug. 20, 2014 /PRNewswire/ -- Acclaimed Actress Amy Brenneman may play a silenced police chief's wife in her new role on "The Leftovers," but she generously lends her voice to help raise awareness for Crohn's disease and ulcerative colitis in a newly refreshed public service awareness campaign. To view the multimedia assets associated with this release, please click...

2014-08-20 08:28:32

The Crohn's & Colitis Foundation of America Teams Up with Pfizer Inc.'s Centers for Therapeutic Innovation to Support Novel Translational Research in Inflammatory Bowel Disease NEW YORK, Aug. 20, 2014 /PRNewswire-USNewswire/ -- The Crohn's & Colitis Foundation of America (CCFA) announces an agreement with Pfizer Inc.'s Centers for Therapeutic Innovation (CTI) to identify and support the potential development and translation of research in the area of inflammatory bowel disease...

2014-08-14 04:21:51

CAMBRIDGE, Mass. and HERZLIYA-PITUACH, Israel, Aug. 14, 2014 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX First North Premier, Stockholm: "IMNP"), announced today its operating results for the quarter ended June 30, 2014. Dr. Daniel Teper, Chief Executive Officer of Immune Pharmaceuticals, Inc., stated: "Following the completion of a $10.2 million capital raise in March 2014, in the second quarter, we have been able to advance the preparation of Phase II clinical trials...

2014-08-12 08:31:26

Study Aims To Enroll 10,000 Individuals With Inflammatory Bowel Disease MOUNTAIN VIEW, Calif., Aug. 12, 2014 /PRNewswire/ -- 23andMe, the leading personal genetics company today announced an agreement with Pfizer Inc. in which the companies will aim to enroll 10,000 people with Inflammatory Bowel Disease (IBD) in a research initiative designed to explore the genetic factors associated with the onset, progression, severity and response to treatments for IBD. Approximately 1.4...

2014-08-08 23:08:14

Sigma-Tau Pharmaceuticals Goal is to Broaden Consumer Awareness of VSL#3 and Meet Consumers at the Shelf; Pharmacy Cards Rolling Out at Stores Nationwide Gaithersburg, MD (PRWEB) August 07, 2014 Consumers have gotten used to seeing shelf cards in place of full product packages in certain categories of products, such as cold and flu, when either price or ingredients are deemed an issue for the store. Now, in an effort to offer consumers a different type of probiotic, one that is up to 10...


Word of the Day
abrosia
  • Wasting away as a result of abstinence from food.
The word 'abrosia' comes from a Greek roots meaning 'not' and 'eating'.